Buy Prosoma 500 mg Tablets Online
Prosoma 500 mg Tablets (generic Carisoprodol 500 mg, SKU: 00103) is a centrally acting skeletal muscle relaxant indicated for the short-term relief of acute, painful musculoskeletal conditions. At Alldays Medicine, verify local dispatch via interactive PIN Code Check (delivery window: 10–12 days), compare tiered volume savings, and review critical safety guidance.
Clinical Snapshot, Tiered Pricing & Specifications
|
Attribute
|
Detail
|
|
Active Pharmacological Ingredient
|
Carisoprodol 500 mg per tablet
|
|
Pharmacological Class
|
Centrally Acting Skeletal Muscle Relaxant (CNS depressant / Schedule IV profile)
|
|
Primary Clinical Indication
|
Short-term (2–3 weeks) relief of acute muscle spasm associated with musculoskeletal discomfort
|
|
Product Code / SKU
|
00103
|
|
Manufacturer / Presentation
|
Carisoprodol 500 mg Oral Tablet
|
|
Estimated Delivery Window
|
10–12 Business Days (PIN-code regional courier verified)
|
Available Volume Pack Size & Tier Pricing Matrix
|
Pack Option
|
Total Price (USD)
|
Effective Unit Scale Value / Display Tier
|
|
40 Pills Bundle
|
$18.00
|
$0.45 tier display
|
|
60 Pills Bundle
|
$24.00
|
$0.40 tier display
|
|
120 Pills Bundle
|
$42.00
|
$0.35 tier display
|
|
200 Pills Bundle
|
$60.00
|
$0.30 tier display
|
Mechanism of Action: How Prosoma 500 mg Works
- Central Nervous System Modulation: Metabolized primarily to meprobamate, carisoprodol modifies interneuronal activity in the spinal cord and descending reticular formation of the brain, reducing polysynaptic reflex transmission associated with painful skeletal muscle spasms.
- Pharmacokinetic Profile: Rapidly absorbed post-oral administration; peak plasma levels ($T_{max}$) achieved within ~1.5 to 2 hours. Metabolized in the liver (CYP2C19) with a terminal half-life of roughly 2 hours (meprobamate metabolite half-life ~10 hours).
Administration Instructions & Safety Guidelines
- Administration Technique: Typically taken three times daily and at bedtime for short-term courses (generally not exceeding 2–3 weeks). Swallow whole with water; may be taken with or without food. Frequency ceiling: strict adherence to prescribing physician limits to prevent accumulation of the meprobamate metabolite.
- Clinical Screening & Telehealth Verification: Short-term muscle relaxant therapy requires clinical evaluation of baseline renal/hepatic clearance, history of substance use disorder, and concurrent depressant exposure.
- Critical Contraindications & Interactions:
Absolute Contraindication: Acute intermittent porphyria, known hypersensitivity to carisoprodol, meprobamate, or related carbamates.
CNS Depressant & Opioid Synergy: Co-administration with central nervous system depressants (opioids, benzodiazepines, sedative-hypnotics, alcohol) exponentially increases risk of severe sedation, respiratory depression, psychomotor impairment, and coma. CYP2C19 inhibitors (omeprazole, fluvoxamine) can elevate carisoprodol plasma levels.
Adverse Effects Profile
- Common: Drowsiness, dizziness, vertigo, ataxia, headache, tachycardia, agitation, blurred vision.
- Emergency Indicators: Severe paradoxical CNS excitation, hypotension/syncopal episodes, severe allergic reactions (anaphylaxis/angioedema), or signs of respiratory depression/overdose. Abrupt discontinuation after prolonged high-dose use can trigger withdrawal symptoms (insomnia, anxiety, abdominal cramps, hallucinations).
Frequently Asked Questions
Q: How long can I safely take Prosoma 500 mg?
A: Carisoprodol is FDA-indicated strictly for short-term use (typically 2 to 3 weeks) for acute muscle spasm, as efficacy for chronic use is not established and dependence risk exists.
Q: Does Prosoma 500 mg cause drowsiness?
A: Yes. Sedation, dizziness, and psychomotor impairment are common; avoid driving, operating machinery, or performing hazardous tasks until individual drug response is known.
Q: Can I combine Prosoma 500 mg with alcohol or opioids?
A: No. Combining carisoprodol with alcohol, opioids, or benzodiazepines causes dangerous additive central nervous system and respiratory depression.
Clinical Disclaimer: Safe use, duration bounds, and suitability for acute muscle spasm should be verified with a qualified physician or telehealth practitioner.